Free shipping on all orders over $ 500

Vutrisiran

Cat. No. M40955

All AbMole products are for research use only, cannot be used for human consumption.

Vutrisiran Structure
Synonym:

ALN-TTRsc02

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Vutrisiran is a liver-directed small interfering RNA (siRNA) that targets transthyretin protein (TTR) mRNA and can be used in TTR-mediated amyloidosis studies.

Chemical Information
Molecular Weight 16345
CAS Number 1867157-35-4
Form Solid
Storage 4°C, dry, sealed
References

[1] Susan J Keam. Drugs. Vutrisiran: First Approval

[2] No authors listed. Am J Health Syst Pharm. Vutrisiran Sodium

[3] Bahru A Habtemariam et al. Clin Pharmacol Ther. Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects

Related Transthyretin (TTR) Products
Tafamidis

Tafamidis is a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade, with EC50s of 2.7-3.2 μM to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR.

A 1120

A 1120 is a high-affinity antagonist of retinol-binding protein 4 (RBP4) with a Ki value of 8.3 nM that disrupts the interaction between RBP4 and its conjugate transthyretin.

Acoramidis hydrochloride

Acoramidis (AG10) hydrochloride is an orally active, selective stabilizer of the thyroxine transporter (TTR (transthyretin)) that is effective against both wild-type and V1221 mutant types. Acoramidis (AG10) hydrochloride can be used for the study of transthyroxine amyloidosis.

Acoramidis

Acoramidis (AG10) is an orally active, selective stabilizer of the thyroxine transporter (TTR) that is effective against both wild-type and V1221 mutant types.

WT-TTR inhibitor 1

WT-TTR inhibitor 1 is a wild-type Transthyretin (WT-TTR) inhibitor with 29.05% inhibition at 100 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Vutrisiran, ALN-TTRsc02 supplier, Transthyretin (TTR), inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.